NYSE:CLHousehold Products
Does Colgate-Palmolive's (CL) New Board Voice and Dividend Bump Hint at a Shifting Capital Play?
Colgate-Palmolive recently added Christopher S. Boerner, Ph.D., Chair and CEO of Bristol-Myers Squibb, to its Board and modestly lifted its quarterly dividend from US$0.52 to US$0.53 per share, effective for the second quarter of 2026.
The combination of fresh healthcare-focused board expertise and a higher annualized dividend of US$2.12 subtly reshapes how investors may view Colgate-Palmolive’s governance and capital return profile.
Next, we’ll examine how the dividend increase interacts...